Susquehanna Fundamental Investments’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Susquehanna Fundamental Investments’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-28,551	Closed	-$1.5M	–	1564
2021 Q3	$1.5M	Sell	28,551 -7,525	-21%	-$447K	0.03%	704
2021 Q2	$2.48M	Buy	36,076 +33,276	+1,188%	+$2.54M	0.05%	526
2021 Q1	$216K	Buy	+2,800	New	+$258K	﹤0.01%	1378

Other funds holding LKFT

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna Fundamental Investments's LKFT Position: Q4 2021 in Review

Susquehanna Fundamental Investments sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2021, closing a stake of 28,551 shares — an estimated $1.5M sold.

Susquehanna Fundamental Investments first reported a position in LKFT in Q1 2021 and held it in 3 quarters. The position peaked at $2.48M in Q2 2021. 83 funds tracked by Wall St. Rank hold LKFT as of Q4 2021.

Susquehanna Fundamental Investments reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2021 after selling out during the quarter.
Susquehanna Fundamental Investments sold 28,551 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2021, an estimated $1.5M.
Susquehanna Fundamental Investments first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2021 and held it in 3 quarters.
Susquehanna Fundamental Investments's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.48M in Q2 2021.
83 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2021, filed 14 Feb 2022.